Loading the map…
Private limited company registered in Kenley, classed under “Buying and selling of own real estate” and 2 other activities.
Headline figures
FY to Mar 2026 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Creditors due within a year | ||||
| Net current assets | ||||
| Creditors due after a year | ||||
| Ratios | ||||
| Cash ratioCash for every £1 owed within a year | ||||
3 balance-sheet lines and 1 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Opulence Homes do?
Private limited company registered in Kenley, classed under “Buying and selling of own real estate” and 2 other activities.
›How much turnover does Opulence Homes make?
Answered in the full report
›Is Opulence Homes profitable?
Opulence Homes's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Opulence Homes?
Answered in the full report
›Where is Opulence Homes based?
Its registered office is 6 Frobisher Close, Kenley, CR8 5HF, in Kenley.
›When was Opulence Homes founded?
Opulence Homes Ltd was incorporated on 20 October 2017.
›Is Opulence Homes still trading?
The register lists Opulence Homes Ltd as active.